ALGERI, MATTIA
 Distribuzione geografica
Continente #
AS - Asia 509
NA - Nord America 323
EU - Europa 255
SA - Sud America 89
AF - Africa 12
Totale 1.188
Nazione #
SG - Singapore 405
US - Stati Uniti d'America 303
IT - Italia 87
BR - Brasile 76
DE - Germania 54
GB - Regno Unito 28
CN - Cina 24
NL - Olanda 21
AT - Austria 19
FI - Finlandia 19
VN - Vietnam 15
IN - India 14
CA - Canada 9
PK - Pakistan 9
SA - Arabia Saudita 8
BD - Bangladesh 7
FR - Francia 6
HK - Hong Kong 6
MX - Messico 6
UA - Ucraina 6
AR - Argentina 5
PL - Polonia 5
TR - Turchia 5
ZA - Sudafrica 5
VE - Venezuela 4
ES - Italia 3
IE - Irlanda 3
TN - Tunisia 3
TW - Taiwan 3
BB - Barbados 2
ID - Indonesia 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
MA - Marocco 2
UZ - Uzbekistan 2
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RU - Federazione Russa 1
SE - Svezia 1
Totale 1.188
Città #
Singapore 217
Santa Clara 154
Munich 34
Ashburn 22
Beijing 21
Rome 20
Helsinki 12
Nuremberg 12
London 11
Milan 11
Boardman 9
Palermo 8
Amsterdam 7
New York 7
Hong Kong 6
Turku 6
Vallefiorita 6
Dhaka 5
Ho Chi Minh City 5
Hanoi 4
Islington 4
Johannesburg 4
Riyadh 4
San Francisco 4
San Nicola Manfredi 4
Toronto 4
Allen 3
Ankara 3
Boston 3
Brooklyn 3
Gavoi 3
Los Angeles 3
Mexico City 3
New Delhi 3
Pontirolo Nuovo 3
Pune 3
San Jose 3
São Paulo 3
Teverola 3
Vienna 3
Warsaw 3
Belo Horizonte 2
Bridgetown 2
Buffalo 2
Calgary 2
Charlotte 2
Curitiba 2
Detroit 2
Guarulhos 2
Jeddah 2
Landshut 2
Miami 2
Nairobi 2
Naples 2
Pittsburgh 2
Sassari 2
Seattle 2
Secaucus 2
Tam Bình 2
Tashkent 2
Tehran 2
Tunis 2
Witney 2
Xi'an 2
Abaetetuba 1
Allentown 1
Amman 1
Angra dos Reis 1
Araquari 1
Araraquara 1
Arezzo 1
Asunción 1
Aubervilliers 1
Bandung 1
Bauru 1
Belhaven 1
Belém de São Francisco 1
Betim 1
Blythewood 1
Brandon 1
Brest 1
Buenos Aires 1
Buritizeiro 1
Campinas 1
Campos dos Goytacazes 1
Canoas 1
Cao Lanh 1
Caracas 1
Caraguatatuba 1
Caruaru 1
Casablanca 1
Caxias do Sul 1
Centro Municipality 1
Chennai 1
Cheyenne 1
Chicago 1
City of London 1
Cleveland 1
Corumbá 1
Council Bluffs 1
Totale 728
Nome #
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 36
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 35
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 32
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia 32
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation 20
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia 20
Remestemcel-L for the treatment of graft versus host disease 18
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia 17
FINAL RESULTS OF THE PHASE 3 STUDIES NORTHSTAR-2 AND NORTHSTAR-3 IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA (TDT): SUBGROUP ANALYSIS OF ITALIAN PATIENTS TREATED WITH BETIBEGLOGENE AUTOTEMCEL (BETI-CEL), LENTIGLOBIN FOR THALASSEMIA 17
GENERATION OF CYTOTOXIC T LYMPHOCYTES BY DONOR-SPECIFIC CSE PEPTO WT1 AND WITH CYTOTOXIC ACTIVITY TOWARDS LEUKEMIC BLASTS OF THE PATIENT FOR ADOPTIVE IMMUNOTHERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS. 17
Autologous gene therapy for hemoglobinopathies: From bench to patient's bedside 17
Alpha/beta T-cell depleted Haploidentical HSCT followed by infusion of donor lymphocytes transduced with inducible caspase9 gene is safe and effective for patients with erythroid disorders 17
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population 17
T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica 16
IMPACT OF POST-TRANSPLANT INFUSION OF DONOR T CELLS GENETICALLY MODIFIED WITH INDUCIBLE CASPASE 9 SUICIDE GENE (BPX-501 CELLS) ON CHILDREN WITH LEUKEMIA GIVEN ALPHA-BETA T-CELL DEPLETED HAPLO-HSCT 16
TCRab/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders 15
HLA-haploidentical TCRab1/CD191-depleted stem cell transplantation in children and young adults with Fanconi anemia 15
Comprehensive characterization of bone-marrow mesenchymal stromal cells isolated from patients affected by primary immunodeficiency 15
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor 15
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease 15
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (Tbdepl-Haplohsct) in Children with Non-Malignant Disorders 15
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 14
T-Cell Depleted HLA-Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (haplo-HSCT) Followed By Donor Lymphocyte Infusion with T Cells Transduced with the Inducible Caspase 9 (iC9) Suicide Gene in Children with Hematological Malignancies 14
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells isolated from pediatric patients affected by acute myeloid leukemia 14
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis 13
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 13
ABATACEPT REDUCES ACUTE GVHD INCIDENCE IN PEDIATRIC PATIENTS TRANSPLANTED FROM HLA-MISMATCHED UNRELATED DONORS 13
CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia 13
BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) FACILITATES HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT IN CHILDREN WITH BOTH HEMATOLOGICAL MALIGNANCIES AND NON-MALIGNANT CONDITIONS 13
Long-Term Outcome of Children with Acute Leukemia (AL) Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 13
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 13
Allogeneic CD19-CAR T cells: a promising treatment for pediatric patients with highly refractory BCP-ALL relapsing after allogeneic hematopoietic stem cells transplant (allo-HSCT) 12
A new BSA-based Threshold Predicts Optimal PBSC Collection in T-cell Depleted HLA-haploidentical Stem Cell Transplantation 12
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) in Children with Myelodysplastic Syndromes 12
Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA-Haploidentical HSCT (haplo-HSCT) in Children with Malignant or Non-Malignant Disorders 12
Academic, Phase I/II Trial on T Cells Expressing a Second Generation, CD19-Specific Chimeric Antigen Receptor (CAR) and Inducible Caspase 9 Safety Switch for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) and B-Cell Non-Hodgkin Lymphoma (B-NHL) in Children 12
Alpha/Beta T-Cell and B-Cell Depletion HLA-Haploidentical Hematopoietic Stem Cell Transplantation Is an Effective Treatment for Children/Young Adults with Acute Leukemia 12
Clinical Outcome and Immune Recovery after Adoptive Infusion of BPX-501 Cells (donor T cells transduced with iC9 suicide gene) in Children with Hemoglobinopathies and Diamond-Blackfan Anemia Given α/β T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation (HSCT) 12
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 12
A new promising, third-generation (3RD) CAR-CD30 T cells therapy for CD30+lymphoma patients 12
The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia 11
Outcomes of children with primary immunodeficiencies receiving alpha/beta T-cell depleted HLA-haplo-HSCT followed by infusion of lymphocytes transduced with the inducible caspase 9 (iC9) suicide gene 11
Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease 11
Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease and Graft Failure in Patients with Non-Malignant Disorders: Results of a Multicentre, Randomized, Open-Label Study 11
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation 11
TCRαβ +/CD19 + - Depleted HLA-Haploidentical Hematopoietic Stem Cell Traansplantation in Pediatric Patient with Fanconi Anemia 11
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome 11
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders 11
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study 11
NIRMATRELVIR/RITONAVIR AND TIXAGEVIMAB/CILGAVIMAB AS SARS-COV-2 TREATMENT IN PEDIATRIC AND YOUNG ADULT PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR CD19-DIRECTED CAR T-CELL TREATMENT 10
Natural history of Ras‐associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 10
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 10
Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Transfusion-Dependent β-Thalassemia Treated at the Bambino Gesù Children's Hospital, Rome, Italy 10
Fecal Microbiota Transplantation in Children to Treat Acute GVHD or multi-drug Resistant Bacteria Colonization 10
Busulfan, Cyclophosphamide and Melphalan As Conditioning Regimen for Pediatric Patients with AML in 1st or 2nd CR: A Retrospective Analysis from the AIEOP HSCT Registry 10
Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) Expand and Persist over Time after Post-Allograft Infusion in Patients Given αβ T-Cell and B-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (αβ haplo-HSCT) Contributing to Accelerate Immune Recovery 10
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 10
Use of emapalumab in the peri-transplant period to prevent graft failure in patients at risk 10
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Cerebral Adrenoleukodystrophy: Outcomes by Donor Cell Source And Match, Conditioning Regimen, And Stage of Cerebral Disease 10
Phenotypic and functional characterization of nk cells in αβt-cell and b-cell depleted haplo-hsct to cure pediatric patients with acute leukemia 10
Improved T- and B-Cell Neogenesis in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Combined with the Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (Rivo-cel) 9
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children 9
Outcome of children with acute leukemia given allogeneic HSCT either from an unrelated donor (UD-HSCT) or from an HLA-partially matched relative after αß-T cell/B-cell depletion (αßhaplo-HSCT) 9
Characterization of Bone Marrow Infiltrate of Immune-mediated Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation 9
Strategies To Increase CAR T-Cell Safety and to Prevent Epitope Masking In CAR plus B-Cell Leukemia Blasts 9
T- and B-Cell Neogenesis Recovers Efficiently in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Followed By Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (BPX-501 cells) 9
Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network 9
Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL? 9
CD19 REDIRECTED CAR NK CELLS ARE EQUALLY EFFECTIVE BUT LESS TOXIC THAN CAR T CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA 9
THE USE OF BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) TOGETHER WITH HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT TO TREAT CHILDREN WITH HEMOGLOBINOPATHIES AND ERYTHROID DISORDERS 9
Management of pediatric patients with anti-HLA antibodies undergoing T-cell depleted haploidentical hematopoietic stem cell transplantation 9
Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: Gut microbiota profiling, infectious and clinical outcomes 9
Circulating Extracellular Vesicles Impair Mesenchymal Stromal Cell Differentiation Favoring Adipogenic Rather than Osteogenic Differentiation in Adolescents with Obesity 9
Pembrolizumab (and friends) in pediatric malignancies: should we consider Hodgkin lymphoma a world of its own? 9
Treosulfan Exposure in Pediatric Hematopoietic Stem Cell Transplantation is Associated with Early Toxicity but not with event-free Survival 8
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study 8
Outcome of children with ALL in second complete remission transplanted from an unrelated donor: a retrospective analysis 8
Novel compound heterozygous mutations in il-7 receptor α gene in a 15-month-old girl presenting with thrombocytopenia, normal t cell count and maternal engraftment 8
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 8
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 8
Cord blood transplantation for acute leukemia 8
Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders 8
P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL 8
Patient-Derived Chimeric Antigen Receptor T-Cell Production Based on a Gammaretroviral Vector Platform Is Not Associated with Generation of CAR+ Leukemia Blasts 7
Updated Analysis on the Outcomes of Children with Acute Leukemia (AL) Receiving an Alpha/Beta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 7
Unmanipulated donor lymphocyte infusion (dli) after ab-t and b-cell depleted haploidentical stem cell transplantation 7
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy 6
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 6
HLA EVOLUTIONARY DIVERGENCE INFLUENCES OUTCOMES OF ALLOGENEIC SCT FROM UNRELATED DONOR IN PEDIATRIC PATIENTS AND YOUNG ADULTS AFFECTED BY MALIGNANT DISORDERS 6
αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes 6
OUTCOMES OF HLA-MISMATCHED HSCT WITH TCRAB/CD19 DEPLETION OR POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR INBORN ERRORS OF IMMUNITY: ANALYSIS BY EBMT IEWP HAPLOHSCT IN IEI STUDY GROUP 6
Reconstitution Dynamics and Impact on Clinical Outcomes of Mucosal-Associated Invariant T-Cells in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation 6
Hematopoietic Stem Cell Transplantation in Thalassemia 6
Lymphocyte Collection for Generation of CAR T-cells in Pediatric Patients: A Single Center Experience 6
Outcome of Children with Wiskott-Aldrich Syndrome (WAS) Given TCR Alpha-Beta/CD19 Depleted Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Haploidentical Relative 6
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia 6
Mucosal-Associated Invariant T (MAIT) Cells Are Functionally Impaired in Pediatric Patients Following HCT and Their Recovery Is Associated with the Onset of GvHD 6
Effective rapid diagnosis of bacterial bloodstream infections by t2 magnetic resonance technology in pediatric hematopoietic stem cell transplantation 6
Implementation of a quality system for running a cell and gene therapy clinical trial within a JACIE-accredited transplant program 6
Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation 6
Totale 1.170
Categoria #
all - tutte 18.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 0 12 0
2024/20251.185 4 0 3 402 66 165 60 29 95 70 59 232
2025/2026190 75 115 0 0 0 0 0 0 0 0 0 0
Totale 1.387